D Young patent opposition analysis

The comprehensive analysis of D Young opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by D Young

Patent NumberTitleApplicantOpposition DateOpposition Company
Bi-Layer Pharmaceutical Tablet FormulationVIIV HEALTHCARE COMPANYAug 26, 2026TEVA PHARMACEUTICAL INDUSTRIES LTD
High Concentration Vegf Receptor Fusion Protein Containing FormulationsREGENERON PHARMACEUTICALS, INC.Aug 26, 2026HAMPTON KNOWLES
Smoking Substitute SystemIMPERIAL TOBACCO LIMITEDAug 25, 2026NICOVENTURES TRADING LIMITED
Non-Heating Type Flavor InhalerJAPAN TOBACCO INC.Aug 25, 2026NICOVENTURES TRADING LIMITED
Liquid For AtomizationJAPAN TOBACCO INC.Aug 25, 2026NICOVENTURES TRADING LIMITED
Tobacco Medium And Aerosol-Generating Article Comprising The SameKT & G CORPORATIONAug 25, 2026NICOVENTURES TRADING LIMITED
Method For Producing Vegetable Protein-Processed Product Having Improved Food TextureAMANO ENZYME INC.Aug 21, 2026INTERNATIONAL N&H DENMARK APS
Airflow Management For Vaporizer DeviceJUUL LABS, INC.Aug 20, 2026NICOVENTURES TRADING LIMITED
Improved Method Of Producing A Liquid Tobacco ExtractPHILIP MORRIS PRODUCTS S.A.Aug 12, 2026NICOVENTURES TRADING LIMITED
Crystal Forms Of 6-(Cyclopropanecarboxamido)-4-((2-Methoxy-3-(1-Methyl-1H-1,2,4-Triazol-3-Yl)Phenyl)Amino)-N-(Methyl-D3)Pyridazine-3-CarboxamideBRISTOL-MYERS SQUIBB COMPANYAug 11, 2026HAMPTON KNOWLES